We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+10.94%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$6.38B
AUM Growth
+$250M
Cap. Flow
-$95M
Cap. Flow %
-1.49%
Top 10 Hldgs %
24.3%
Holding
176
New
25
Increased
62
Reduced
40
Closed
19

Top Buys

Rank Stock Value
1
GTLB icon
GitLab
GTLB
+$45.6M
2
ROL icon
Rollins
ROL
+$37.7M
3
CPRT icon
Copart
CPRT
+$36.7M
4
MDB icon
MongoDB
MDB
+$36.7M
5
TTD icon
Trade Desk
TTD
+$36.6M

Top Sells

Rank Stock Value
1
CRWD icon
CrowdStrike
CRWD
+$76.4M
2
PANW icon
Palo Alto Networks
PANW
+$64.1M
3
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
+$60.1M
4
LNG icon
Cheniere Energy
LNG
+$51.4M
5
APTV icon
Aptiv
APTV
+$43.1M

Sector Composition

Rank Sector Weight
1 Healthcare 38.57%
2 Technology 24.76%
3 Industrials 16.51%
4 Consumer Discretionary 8.57%
5 Communication Services 3.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SRPT icon
101
Sarepta Therapeutics
SRPT
$1.64B
$17.5M 0.28%
135,466
+46,247
+52% +$5.67M
INSM icon
102
Insmed
INSM
$22B
$17.2M 0.27%
635,185
– –
RARE icon
103
Ultragenyx Pharmaceutical
RARE
$2.56B
$16.8M 0.26%
359,000
– –
IEX icon
104
IDEX
IEX
$17.2B
$16.3M 0.26%
66,694
+12,051
+22% +$2.72M
ALPN
105
DELISTED
Alpine Immune Sciences Inc
ALPN
$16.2M 0.25%
+408,542
New +$12.1M
PEG icon
106
Public Service Enterprise Group
PEG
$38.6B
$15.5M 0.24%
+231,675
New +$14.2M
IDYA icon
107
IDEAYA Biosciences
IDYA
$3.5B
$14.7M 0.23%
335,000
– –
VRSK icon
108
Verisk Analytics
VRSK
$26.1B
$13.9M 0.22%
59,054
+12,499
+27% +$3M
RCKT icon
109
Rocket Pharmaceuticals
RCKT
$351M
$13.2M 0.21%
490,732
– –
JBIO
110
Jade Biosciences
JBIO
$1.22B
$13.2M 0.21%
12,729
+12,381
+3,558% +$9.46M
ALNY icon
111
Alnylam Pharmaceuticals
ALNY
$27.5B
$13M 0.2%
87,000
– –
VCYT icon
112
Veracyte
VCYT
$4.77B
$12.5M 0.2%
564,000
– –
APLS
113
DELISTED
Apellis Pharmaceuticals
APLS
$12.3M 0.19%
209,794
– –
SO icon
114
Southern Company
SO
$109B
$12.1M 0.19%
168,863
-142
-0.1% -$9.8K
GXO icon
115
GXO Logistics
GXO
$5.8B
$11.9M 0.19%
220,750
+580
+0.3% +$31.4K
FANG icon
116
Diamondback Energy
FANG
$56.2B
$11.8M 0.19%
59,524
-50,097
-46% -$8.51M
RVMD icon
117
Revolution Medicines
RVMD
$40.9B
$11.6M 0.18%
361,000
– –
CEG icon
118
Constellation Energy
CEG
$94.1B
$11.6M 0.18%
+62,493
New +$8.87M
NTAP icon
119
NetApp
NTAP
$34.1B
$11.1M 0.17%
+105,504
New +$9.78M
TGTX icon
120
TG Therapeutics
TGTX
$8.19B
$10.9M 0.17%
718,814
+279,340
+64% +$4.45M
MASS icon
121
908 Devices
MASS
$313M
$10.8M 0.17%
1,430,995
– –
AIT icon
122
Applied Industrial Technologies
AIT
$12.6B
$10.3M 0.16%
+52,295
New +$9.55M
EQIX icon
123
Equinix
EQIX
$103B
$10.2M 0.16%
12,357
+2,829
+30% +$2.38M
CMS icon
124
CMS Energy
CMS
$22.7B
$10.2M 0.16%
168,668
-110,412
-40% -$6.4M
SYY icon
125
Sysco
SYY
$40.6B
$9.76M 0.15%
120,249
– –
3 4
5
6 7

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q1 2024 Portfolio in Review

As of Q1 2024, Eventide Asset Management held 176 positions worth $6.38B, up 4.1% from $6.13B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Eventide Asset Management's Q1 2024 filing shows 25 new, 62 increased, 40 reduced and 19 closed positions. Its largest new stake was GitLab: 695,704 shares worth $40.6M. The largest sale was CrowdStrike, an estimated $76.4M.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets, down from 39% a quarter earlier, followed by Technology and Industrials.

  • Eventide Asset Management's largest Q1 2024 buy was GitLab: 695,704 shares worth $40.6M.
  • Eventide Asset Management added most to Rollins in Q1 2024, an estimated $37.7M increase.
  • Eventide Asset Management's biggest Q1 2024 reduction was CrowdStrike, cutting an estimated $76.4M.
  • Eventide Asset Management fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $60.1M.
  • Eventide Asset Management's ten largest holdings make up 24% of its $6.38B portfolio in Q1 2024.
  • Eventide Asset Management opened 25 new positions and closed 19 in Q1 2024.
  • Eventide Asset Management's portfolio value rose 4.1% quarter-over-quarter to $6.38B.

Based on Eventide Asset Management's 13F filing for Q1 2024, filed 15 May 2024.